Holt Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.58M Sell
18,734
-252
-1% -$58.7K 0.62% 35
2025
Q4
$3.93M Sell
18,986
-17
-0.1% -$3.36K 0.53% 37
2025
Q3
$3.52M Buy
19,003
+60
+0.3% +$10.3K 0.57% 37
2025
Q2
$2.89M Sell
18,943
-39
-0.2% -$6K 0.5% 41
2025
Q1
$3.15M Sell
18,982
-131
-0.7% -$20.5K 0.48% 36
2024
Q4
$2.76M Sell
19,113
-214
-1% -$33.2K 0.42% 42
2024
Q3
$3.13M Sell
19,327
-98
-0.5% -$15.6K 0.48% 35
2024
Q2
$2.84M Sell
19,425
-33
-0.2% -$4.91K 0.61% 31
2024
Q1
$3.08M Sell
19,458
-185
-0.9% -$29.4K 0.51% 34
2023
Q4
$3.08M Sell
19,643
-100
-0.5% -$15.3K 0.55% 33
2023
Q3
$3.07M Buy
19,743
+411
+2% +$67.8K 0.6% 33
2023
Q2
$3.2M Buy
19,332
+115
+0.6% +$18.6K 0.61% 33
2023
Q1
$2.98M Sell
19,217
-224
-1% -$36.2K 0.6% 34
2022
Q4
$3.43M Sell
19,441
-794
-4% -$137K 0.69% 30
2022
Q3
$3.31M Sell
20,235
-75
-0.4% -$12.7K 0.99% 24
2022
Q2
$3.6M Sell
20,310
-1,416
-7% -$252K 0.75% 29
2022
Q1
$3.85M Sell
21,726
-830
-4% -$141K 0.7% 31
2021
Q4
$3.86M Sell
22,556
-309
-1% -$50.6K 0.68% 31
2021
Q3
$3.69M Buy
22,865
+189
+0.8% +$32.2K 0.7% 32
2021
Q2
$3.74M Buy
22,676
+65
+0.3% +$10.8K 0.72% 32
2021
Q1
$3.72M Buy
22,611
+1,221
+6% +$198K 0.76% 29
2020
Q4
$3.37M Buy
21,390
+210
+1% +$31K 0.76% 29
2020
Q3
$3.15M Sell
21,180
-495
-2% -$73.2K 0.82% 28
2020
Q2
$3.05M Buy
21,675
+330
+2% +$48.1K 0.84% 27
2020
Q1
$2.8M Sell
21,345
-211
-1% -$29.9K 0.91% 26
2019
Q4
$3.14M Sell
21,556
-105
-0.5% -$14.2K 0.78% 30
2019
Q3
$2.8M Sell
21,661
-50
-0.2% -$6.59K 0.77% 31
2019
Q2
$3.02M Sell
21,711
-100
-0.5% -$13.8K 0.85% 29
2019
Q1
$3.05M Sell
21,811
-1,935
-8% -$259K 0.88% 25
2018
Q4
$3.06M Sell
23,746
-30
-0.1% -$4.18K 0.99% 25
2018
Q3
$3.29M Sell
23,776
-1,009
-4% -$134K 0.93% 28
2018
Q2
$3.01M Sell
24,785
-440
-2% -$54.9K 0.9% 28
2018
Q1
$3.23M Buy
25,225
+175
+0.7% +$23.7K 0.99% 23
2017
Q4
$3.5M Sell
25,050
-220
-0.9% -$30.6K 1.11% 20
2017
Q3
$3.29M Buy
25,270
+125
+0.5% +$16.6K 1.07% 23
2017
Q2
$3.33M Sell
25,145
-275
-1% -$35.1K 1.15% 22
2017
Q1
$3.17M Sell
25,420
-915
-3% -$109K 1.11% 23
2016
Q4
$3.03M Sell
26,335
-670
-2% -$77.4K 1.12% 21
2016
Q3
$3.19M Sell
27,005
-80
-0.3% -$9.71K 1.25% 18
2016
Q2
$3.29M Buy
27,085
+300
+1% +$34.1K 1.35% 15
2016
Q1
$2.9M Hold
26,785
1.28% 19
2015
Q4
$2.75M Buy
26,785
+40
+0.1% +$4.02K 1.24% 20
2015
Q3
$2.5M Buy
26,745
+470
+2% +$45.5K 1.04% 21
2015
Q2
$2.56M Sell
26,275
-505
-2% -$50.6K 1.03% 22
2015
Q1
$2.69M Sell
26,780
-165
-0.6% -$16.8K 1.1% 22
2014
Q4
$2.82M Sell
26,945
-515
-2% -$54.3K 1.2% 16
2014
Q3
$2.93M Buy
27,460
+26,560
+2,951% +$2.75M 1.33% 15
2014
Q2
$94K Hold
900
0.05% 113
2014
Q1
$88K Hold
900
0.05% 116
2013
Q4
$82K Buy
+900
New +$82.9K 0.05% 123

Other funds holding JNJ

Holt Capital Partners's JNJ Position: Q1 2026 in Review

Holt Capital Partners reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2026, selling an estimated $58.7K and leaving 18,734 shares worth $4.58M. The position accounts for 0.62% of the portfolio, ranked #35.

Holt Capital Partners first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Holt Capital Partners held 18,734 shares of Johnson & Johnson worth $4.58M as of Q1 2026.
  • Holt Capital Partners sold 252 Johnson & Johnson shares in Q1 2026, an estimated $58.7K.
  • Johnson & Johnson made up 0.62% of Holt Capital Partners's portfolio in Q1 2026, its #35 holding.
  • Holt Capital Partners first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Holt Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.